Independence/Objectivity Certification. The IRO(s) shall include in its report(s) to Gambro a certification or sworn affidavit that it has evaluated its professional independence and/or objectivity, as appropriate to the nature of the engagement, with regard to the Claims Review, Unallowable Cost Review, or Stat Lab Systems Review and that it has concluded that it is, in fact, independent and/or objective.
Independence/Objectivity Certification. The IRO shall include in its report(s) to HealthSouth a certification or sworn affidavit that it has evaluated its professional independence and/or objectivity, as appropriate to the nature of the engagement, with regard to the Cost Reporting Engagement, Unallowable Cost Review, or Billing Engagement and that it has concluded that it is, in fact, independent and/or objective.
Independence/Objectivity Certification. The IRO shall include in its report(s) to CVS a certification or sworn affidavit that it has evaluated its professional independence and objectivity, as appropriate to the nature of the engagement, with regard CVS Caremark Corporate Integrity Agreement to the Government reimbursement Review and that it has concluded that it is, in fact, independent and objective.
Independence/Objectivity Certification. The IRO shall include in its report(s) to Serono a certification or sworn affidavit that it has evaluated its professional independence and/or objectivity, as appropriate to the nature of the engagement, with regard to the applicable Review and that it has concluded that it is, in fact, independent and/or objective. 21 Corporate Integrity Agreement Serono Holding, Inc. Case 1:05-cr-10282-RCL Document 7-5 Filed 12/21/05 Page 21 of 27 G. Disclosure Program. Serono presently has a disclosure program designed to facilitate communications relating to compliance with Federal health care program and FDA requirements and with Serono's policies (Disclosure Program). During the term of this CIA, Serono shall continue to maintain a Disclosure Program that includes a mechanism (e.g., a toll-free compliance telephone line) to enable individuals to disclose, to the Compliance Officer or some other person who is not in the disclosing individual's chain of command, any identified issues or questions associated with Serono's policies, conduct, practices, or procedures with respect to Federal health care program requirements or FDA requirements believed by the individual to be a potential violation of criminal, civil, or administrative law. Serono shall continue to appropriately publicize the existence of the disclosure mechanism (e.g., via periodic e-mails to employees or by posting the information in prominent common areas). The Disclosure Program shall emphasize a nonretnbution, nonretaliation policy, and shall include a reporting mechanism for anonymous communications for which appropriate confidentiality shall be maintained. Upon receipt of a disclosure, the Compliance Officer (or designee) shall gather all relevant information from the disclosing individual. The Compliance Officer (or designee) shall make a preliminary, good faith inquiry into the allegations set forth in every disclosure to ensure that he or she has obtained all of the information necessary to determine whether a further review should be conducted. For any disclosure that is sufficiently specific so that it reasonably: ( 1) pennits a determination of the appropriateness of the alleged improper practice; and (2) provides an opportunity for taking corrective action, Serono shall conduct an internal review of the allegations set forth in the disclosure and ensure that i:)xxxxx follow-up is conducted. The Compliance Officer (or designee) shall maintain a disclosure log, which shall include a record and s...
Independence/Objectivity Certification. The IRO shall include in its report(s) to King a certification or sworn affidavit that it has evaluated its professional independence and/or objectivity, as appropriate to the nature of the Engagement, with regard to the Engagement and that it has concluded that it is, in fact, independent and/or objective. Corporate Integrity Agreement King Pharmaceuticals, Inc.
Independence/Objectivity Certification. The IRO shall include in its report(s) to Pediatrix a certification or sworn affidavit that it has evaluated its professional independence and/or objectivity, as appropriate to the nature of the engagement, with regard to the Claims Review or Unallowable Cost Review and that it has concluded that it is, in fact, independent and/or objective. Pediatrix Medical Group, Inc. Corporate Integrity Agreement
Independence/Objectivity Certification. The IRO shall include in its report(s) to Polymedica a certification or sworn affidavit that it has evaluated its professional independence and/or objectivity, as appropriate to the nature of the engagement, with regard to the Claims Review or Unallowable Cost Review and that it has concluded that it is, in fact, independent and/or objective.
